A method is described for the assay of 4-hydroxy-3-methoxymandelic acid (I-fMMA) in urine using IIPLC coupled with electrochemical detection. In this method acidified urine is extracted with ethyl acetate which is then washed with the chromatography solvent to back extract HMMA. The solvent is a pH 5·0 citrate buffer. At this pll. HMMA separates clearly from all other electroactive compounds present in urine.
The assay of vanillylmandelic acid (VMA; or HMMA) as a test for neural crest tumours has been widely used for many years. Early methods were cumbersome and non-specific.' but the use of HPLC coupled with electrochemical detection has allowed the development of specific and sensitive assays. Many methods for HMMA estimation are now available. However. wide variations occur between methods. particularly in the way samples are pre-treated. The simplest methods employ only dilution of the sample," the more complex use solvent extraction," evaporation to dryness and redissolution in buffer," or ion exchange resins." Chromatrography conditions also vary from the simple isocratic systems to the more complex gradient elutions.
The aim in developing this assay was to design a procedure that would give a good separation of HMMA from potentially interfering compounds and one that would be technically simple to perform. A stock standard of HMMA was made up to give a concentration of 5·0 mmol/L in 0·1 mol/L HCI. A working standard of 50 umol/L was prepared freshly by diluting the stock in water. Water W.IS glass distilled and stored in glass.
Materials and methods

APPARATUS
CHROMATOGRAPIIY CONDITIONS
The chromatography solvent used was 0·1 M citrate buffer pH 5·0 (96 vol) methanol (4 vol). The solvent was passed through a 0·45 micron filter before use. and then degassed using helium and an ultrasonic bath.
The electrochemical detector was set up as follows: working electrode voltage +0·9 volts. Full scale deflection 100 na. Time constant I.
A 20 ItL sample loop was used and all operations were carried out at ambient temperature.
The system was shut down by washing the column with water for 15 min and then with methanol for 15 min. The column was stored in methanol.
SAMPI.E COI.LECTION AND PREPARATION
Assays for HMMA were performed on 24 h urine collections preserved with 50 ml 2 M HC\. Samples were stored at 4°C until they were assayed.
Prior to loading the samples on to the column. the following clean up procedure was employed: into a III mL glass tube was pipetted 0·2 mL urine or standard and 0·2 mL of 1·0 M hydrochloric acid. followed hy 2·0 mL ethyl acetate. All tubes were mixed hy vortexing on an SMI multi-vortcxer for 00 s. The tubes were centrifuged at 2()(K) rpm for 5 min to separate the phases and then ()·5 mL of the ethyl acetate layer was transferred to a second glass tube containing 1·0 mL of the chromatography solvent. All the tubes were vortexcd for 00 s and then centrifuged for 5 min to separate the phases. As much as possible of the chromatography solvent (lower layer) was transferred to a third glass tube and the tube stood for 15 min before capping. This allowed any residual ethyl acetate to evaporate.
During the running of large batches. it is quite possible for the samples to remain in the citrate buffer at pH 5·0 for several hours. It was therefore necessary to prove the stability of HMMA at this pH. Two standards were prepared. one was made up in 0·1 M IICI and the other in 0·1 M citrate buffer pI-I 5·0. Both standards contained 50 umol/L HMMA; the standard at pH 5·0 was kept at room temperature and the acid standard at 4°C. There was no significant loss of JlMMA at pH 5·0 for at least 24 h.
Results
A reference range was established by assaying urine from 134 patients with hypertension. The mean was 21·6 umol/L, SD 6·04 ( Fig. I ). Forty-five of these urines were assayed by the method of Pisano. I Figure 2 shows the comparison between the two methods. The correlation coefficient was 0·97 and the regression line (HPLC level) ()·93 x (Pisano level) -0·7.
The method as described is linear to at least 120 umol/L. The efficiency of the extraction procedure was assessed by comparison of aqueous standards put through the extraction procedure with appropriately diluted aqueous standards injected directly onto the column. Recovery of HMMA was 75% of the theoretical maximum; the recovery of other compounds measured by this technique is listed in Table I. Addition of HMMA to urines gave recoveries of 94-11I3'10 when compared with aqueous standards assayed at the same time.
Determination of HMMA 173
The precision of the method was studied at three levels. Within-batch precision was estimated by assaying 10 aliquots of the same urine in one analytical run. Between-batch precision was estimated by repeated assay of the same urines over a period of 6 months. Acidified urine was aliquoted and stored frozen at -30°C. Table 2 summarises the precision figures obtained. 
Discussion
The need to use a clean-up procedure is shown by a comparison of Figs. 3(a) and 3(b). Figure  3 (b) is a chromatogram obtained from a urine diluted 20-fold in water and then loaded directly on to the column. A very complex chromatogram is obtained in which HMMA is not clearly resolved from other peaks. This makes an accurate assessment of peak height very difficult. Solvent extraction as described yields a much simpler chromatogram (Fig. 3a ) in which the HMMA 'peak is clearly isolated from all other peaks and the chromatogram is on baseline both before and after elution of HMMA. This enables a very accurate assess-ment of peak height to be made. The peak following HMMA elutes over a minute later and even with an old column that has reduced efficiency. the chromatogram still returns to baseline. This is reflected in the very good between-batch precision figures which were obtained over a 6-month period of routine use. The method of pre-treatment of urines as described is very simple and batches of up to 15 samples have been dealt with in 20 mins. Removal of residual ethyl acetate is necessary as it can cause peak broadening and also an additional late eluting peak.
Potentially, there are many compounds in urine that might co-elute with HMMA and therefore interfere with the assay. To investigate this possibility, 100 umol/L solutions of all the compounds listed in Table 2 were assayed. These compounds are all ones that appear naturally in urine": 7 and all gave peaks when aqueous solutions were loaded directly onto the column. After passing through the clean-up procedure, II of them were undetectable. Peak heights of most of the others were reduced by more than half; only HMMA 4-hydroxymandelic acid and 4-hydroxy-3-methoxyphenyllactic acid had greater than 70'Yo recovery. Two compounds, 3-4-dihydroxyphenylglycol and ::x: --..l \J\ 3-4-dihydroxymandelic acid. did not give significant peaks in urine. All of the others gave peaks that corresponded to peaks in normal urine.
Methods for the assay of catecholamines and their derivatives in urine have historically been troubled with drug interference. In this laboratory. out of 4(KI urines assayed for metadrenalines by the Pisano" technique. lOX (27%) were rejected because of suspected drug interference. These urines were also assayed Ior HMMA and in none of them was drug interference apparent. The peak produced by HMMA is very sharp with a typical peak width at h,lIf height of 5-10 s, depending on column age (the column used to produce the chromatograms in Fig. 3 had performed over 3(KJ assays for HMMA). In none of the lOX urincs was the HMMA peak either split or broadened. All the urines gave excretions of less than 35 !!mo1/24 h. Aqueous solutions of the following drugs did not interfere with the assay: methyldopa. paracetamol, propranolol, p-aminosalicylate. caffeine, atenolol, labetalol. Few drugs are excreted in the free form and therefore assay of aqueous solutions of drugs is of limited use in assessing interference.
It has proven possible to use the method to assay homovanillic acid (HV A) simultaneously with HMMA. The lower recovery of HVA and its greater retention time causes peak spreading and therefore the height of the peak produced is much smaller. Despite this. it has proven possible to screen for elevated levels.
By using the chromatography solvent for the final extraction. the sample closely matches the eluant in composition. The injection peak is therefore small and the baseline never becomes negative. An isocratic solvent avoids baseline drift due to varying solvent composition and avoids the necessity for column re-equilibration between samples.
These refinements yield a very stable baseline which allows the use of an autosampler. In routine use the method has shown very good within-and between-batch precision. it is simple to perform and is very robust.
